Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

731
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
731
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

786
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
786
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

2.6K
The pathophysiology of pneumonia involves the following steps:
2.6K
Pneumonia IV: Management01:28

Pneumonia IV: Management

756
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
756
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

318
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
318
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

3.4K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Corticosteroids in immunocompromised ICU patients with pneumonia: risks, evidence, and clinical practice.

Pneumonia (Nathan Qld.)·2026
Same author

Ivermectin for Critically and Noncritically Ill Hospitalized Patients With COVID-19: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP).

Critical care medicine·2026
Same author

External Validation of the Long-term Pneumonia Mortality Index in a Low- and Middle-Income Country.

American journal of respiratory and critical care medicine·2026
Same author

Precision antibiotic treatment in intensive care unit-acquired lower respiratory tract infections (ICU-LRTIs): contemporary concepts and future directions.

Expert review of anti-infective therapy·2026
Same author

Letter to perpetual observational study of the clinical and microbiological epidemiology of ventilator-associated pneumonia in Europe.

Critical care (London, England)·2026
Same author

Think beyond the standard: anti-MRSA options in community-acquired pneumonia - Authors' reply.

Lancet (London, England)·2026

相关实验视频

Updated: Jan 17, 2026

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

1.4K

固体器官移植后的肺炎

Paula O Narvaez-Ramirez1, Ingrid G Bustos1,2, Cristian C Serrano-Mayorga1,3

  • 1Critical Care Department, Clínica Universidad de La Sabana, Chía, Colombia.

Seminars in respiratory and critical care medicine
|September 24, 2025
PubMed
概括
此摘要是机器生成的。

肺炎对实体器官移植接受者 (SOTRs) 构成重大威胁,增加死亡率. 早期诊断和向治疗对于在SOTR中管理这些感染至关重要.

更多相关视频

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
10:01

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation

Published on: July 10, 2012

21.0K
Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation
07:28

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Published on: October 11, 2024

704

相关实验视频

Last Updated: Jan 17, 2026

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

1.4K
Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
10:01

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation

Published on: July 10, 2012

21.0K
Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation
07:28

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Published on: October 11, 2024

704

科学领域:

  • 移植医学 移植医学
  • 传染性疾病 传染性疾病
  • 肺部病理学 肺部病理学

背景情况:

  • 固体器官移植 (SOT) 在全球上升,增加了SOT接受者 (SOTR) 的数量.
  • 在SOTR中,免疫抑制会增加感染的风险,特别是肺炎,这是导致死亡的主要原因.
  • 肺炎对SOTRs的发病率和死亡率有显著的贡献,感染时间影响了结果.

研究的目的:

  • 审查SOTR肺炎的当前知识,涵盖流行病学,危险因素,病因学和临床特征.
  • 探索 SOTR 肺炎管理中的时间感染模式和挑战.
  • 强调基于证据的战略,以改善SOTRs的结果.

主要方法:

  • 文献综述总结了SOTRs中肺炎的现有数据.
  • 对感染原因的时间趋势的分析. 移植后.
  • 讨论当前的管理准则及其局限性.

主要成果:

  • 肺炎是SOTRs的主要死亡原因,因移植后的时间而有不同的病因.
  • 早期的感染往往涉及医院或供体病原体;晚期的感染往往是社区获得的.
  • 缺乏特定于SOT的指导方针和有限的试验阻碍了基于证据的管理.

结论:

  • 早期实证治疗的启动对于改善SOTR结果至关重要.
  • 及时的微生物诊断,抗菌药物管理和向治疗是必不可少的.
  • 个性化风险评估和本地数据集成可以优化SOTR中的肺炎管理.